HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cytotoxic T cells against a peptide of Yo protein in patients with paraneoplastic cerebellar degeneration and anti-Yo antibody.

Abstract
Anti-Yo antibodies are present in the sera and cerebrospinal fluid of some patients with paraneoplastic cerebellar degeneration (PCD), but there is no evidence that the presence of anti-Yo antibodies causes the Purkinje cell loss seen in PCD patients. We examined the level of cytotoxic T lymphocyte (CTL) activity against a nine-amino acid peptide of the Yo protein using the Human Leukocyte Antigen- (HLA-) based approach called reverse immunogenetics. Mononuclear cells (MNCs) were isolated from the peripheral venous blood and fibroblasts were obtained from the skin of three patients with PCD with anti-Yo antibody. After activating the MNCs of the three patients with the peptide, it showed CTL activity against the Yo protein peptide expressed on autologous fibroblasts. Therefore, CTLs may be involved in the loss of Purkinje cells in PCD.
AuthorsM Tanaka, K Tanaka, S Tokiguchi, K Shinozawa, S Tsuji
JournalJournal of the neurological sciences (J Neurol Sci) Vol. 168 Issue 1 Pg. 28-31 (Sep 15 1999) ISSN: 0022-510X [Print] Netherlands
PMID10500270 (Publication Type: Journal Article)
Chemical References
  • Autoantibodies
  • Autoantigens
  • CDR1 protein, human
  • CDR2 protein, human
  • DNA-Binding Proteins
  • Epitopes
  • Neoplasm Proteins
  • Nerve Tissue Proteins
  • Peptide Fragments
Topics
  • Autoantibodies (blood, cerebrospinal fluid)
  • Autoantigens (immunology)
  • DNA-Binding Proteins (immunology)
  • Epitopes (immunology)
  • Female
  • Genital Neoplasms, Female (complications, immunology)
  • Humans
  • Neoplasm Proteins (immunology)
  • Nerve Tissue Proteins
  • Paraneoplastic Cerebellar Degeneration (blood, cerebrospinal fluid, immunology)
  • Peptide Fragments (immunology)
  • Purkinje Cells (pathology)
  • T-Lymphocytes, Cytotoxic (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: